European Commission

Pharma

After FDA rejection, Regeneron scores EU nod for Lynozyfic

Regeneron is off and running with its launch of linvoseltamab in Europe. In the U.S., the company is awaiting an FDA decision after a prior rejection.

Eric Sagonowsky Apr 28, 2025 10:12am

Sanofi, Novartis CEOs blast EU austerity amid US tariff threat

Apr 23, 2025 12:25am

Pharmas demand changes to stay in EU amid looming Trump tariffs

Apr 16, 2025 10:41am

Eisai and Biogen's Alzheimer's med Leqembi approved in Europe

Apr 16, 2025 7:52am

Europe European Union European pharma Europe pharma EMA CHMP EC

CHMP again backs Leqembi amid flurry of approval recommendations

Feb 28, 2025 10:30am

European Commission EU Europe Brussels EC

European officials approve Novo Holdings' planned Catalent buy

Dec 6, 2024 2:48pm